PillOTC · Liquid · Oral
Creosote Combination
Aconitum Napellus Whole + Amaryllis Belladonna Whole + Antimony Potassium Tartrate + Bryonia Alba Root + Clostridium Tetani Toxoid Antigen (Formaldehyde Inactivated) + Human Sputum, Bordetella Pertussis Infected + Hyoscyamus Niger + Ipecac + Lobaria Pulmonaria + Lobelia Inflata Whole + Phosphorus + Silicon Dioxide + Wood Creosote
1 ACTIVE SUPPLIER — US
openFDA · updated weekly
US1 NDCs
1 active makers
1 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
ATC—
RxCUI (US)—
US makers1 labelers
Packages1
DEA / ScheduleNone
Medicaid dispensing volume
No Medicaid utilization on record for this drug concept yet. Quarterly volume (CMS State Drug Utilization Data) loads with the utilization ETL.
Who makes it1 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Professional Complementary Health Formulas | unknown | 1 | SUPPLYING |
Regulatory & supply events
No recalls, shortages, or registration changes on record for this drug concept.